Test Price
2,800 AED✅ Home Collection Available
STRC Gene (Autosomal Recessive Deafness Type 16) Genetic Test in UAE
Executive Summary & Core Metrics
Accuracy Guarantee:
99.9% Diagnostic Sensitivity via ISO Accredited Processing.
Logistics:
VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM.
Clinical Guidance:
Telephonic Post-Test Clinical Guidance for result interpretation by a Consultant Medical Geneticist.
Insurance:
Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The STRC gene test uses Next-Generation Sequencing (NGS) to detect pathogenic variants responsible for autosomal recessive deafness type 16 (DFNB16), a common cause of prelingual hearing loss. This test provides comprehensive coverage of the STRC gene, including single-nucleotide variants and copy number variations, ensuring a precise molecular diagnosis.
| Feature | Our STRC NGS Test | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Precision | >99.9% analytical sensitivity, full gene coverage including copy‑number variations | ~95% sensitivity, limited to selected exons; may miss large deletions/duplications |
| Methodology | Next‑Generation Sequencing (NGS) – Illumina® NovaSeq™ with bioinformatic validation | Sanger sequencing of individual gene regions |
| Turnaround Time | 3–4 weeks | 6–8 weeks |
Physician Insight & Safety Protocols
Lina Osama Zaki Quteineh (DHA License: 9294403), Consultant Medical Genetics:
"Genetic testing for hearing loss can be a crucial step in understanding the underlying cause. Our NGS-based STRC test offers comprehensive analysis to identify pathogenic variants, but it is essential to correlate results with audiological assessments and family history. I recommend all patients discuss their results with a genetic counsellor to plan appropriate management."
Advisory: Do Not Discontinue Medications
Do not discontinue any prescribed medication or hearing-related therapies without consulting your physician. Genetic test results should not be used to alter ongoing treatments without professional guidance.
Exclusion Criteria & Red Flags
- Exclusion: Minors without legal guardian consent as per Federal Decree-Law No. 4 of 2016 on Medical Liability; individuals unable to provide informed consent.
- ER Red Flags: Sudden sensorineural hearing loss, acute vertigo, or severe tinnitus require immediate emergency ENT evaluation – genetic testing is not appropriate for acute presentations.
- Pre-Test Requirements: A mandatory pre-test genetic counselling session to document family history and early-onset deafness pattern.
Patient FAQ & Clinical Guidance
1. What does the STRC gene test diagnose?
This test identifies pathogenic variants in the STRC gene causing autosomal recessive deafness type 16 (DFNB16), enabling precise molecular diagnosis. It is the most comprehensive method for detecting both single-nucleotide changes and large deletions that are common in STRC-related hearing loss. A positive result confirms the genetic cause, aids in predicting prognosis, and guides family planning decisions.
2. How is the test performed and what is the turnaround time?
A blood draw or dried blood spot sample is collected, and NGS sequencing delivers definitive results in 3–4 weeks. After sample collection, DNA is extracted and enriched for the STRC gene before high-throughput sequencing. Our bioinformatics pipeline filters and classifies variants according to ACMG guidelines, ensuring a clinically actionable report.
3. Is at-home sample collection available in the UAE for this test?
Yes, VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection is available across all UAE emirates daily from 8 AM to 11 PM. Our trained phlebotomists arrive at your doorstep with ISO-certified transport kits, ensuring sample integrity. The service is fully compliant with UAE PDPL data privacy regulations and can be scheduled via WhatsApp at +971 54 548 8731.
UAE Regulatory & Data Privacy Adherence
Regulatory Compliance
This test complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Patient consent and safety are governed by Federal Decree-Law No. 4 of 2016 on Medical Liability. All data is processed in accordance with UAE healthcare regulations.
Clinical & Logistical Metadata
| Test Name | STRC Gene (Autosomal Recessive Deafness Type 16) Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 weeks |
| Sample Type / Matrix | Whole Blood or Dried Blood Spot (DBS) |
| Methodology Used | Next-Generation Sequencing (NGS) |
| ICD-10-CM Code | H90.5 |
| LOINC Code | 81319-1 |
| DHA Facility License & Address | License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians